Valentina Griggio

575 total citations
18 papers, 362 citations indexed

About

Valentina Griggio is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Valentina Griggio has authored 18 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Immunology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Valentina Griggio's work include Chronic Lymphocytic Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Valentina Griggio is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Valentina Griggio collaborates with scholars based in Italy, United States and Czechia. Valentina Griggio's co-authors include Candida Vitale, Marta Coscia, Mario Boccadoro, Chiara Riganti, Myriam Foglietta, Massimo Massaia, Barbara Castella, Daniela Drandi, Marco Ladetto and Rebecca Jones and has published in prestigious journals such as Blood, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Valentina Griggio

17 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valentina Griggio Italy 10 208 193 144 90 75 18 362
Ewa Wąsik‐Szczepanek Poland 10 196 0.9× 279 1.4× 75 0.5× 158 1.8× 79 1.1× 44 396
Pamela Ranghetti Italy 9 168 0.8× 130 0.7× 69 0.5× 73 0.8× 70 0.9× 20 284
Jenny Bulgarelli Italy 10 167 0.8× 178 0.9× 98 0.7× 78 0.9× 153 2.0× 20 389
Noelia Purroy Spain 10 123 0.6× 159 0.8× 88 0.6× 136 1.5× 113 1.5× 18 334
Patricia Johansson Germany 11 130 0.6× 170 0.9× 107 0.7× 166 1.8× 105 1.4× 21 373
Zsolt Zoltán Fülöp Romania 9 142 0.7× 85 0.4× 87 0.6× 103 1.1× 121 1.6× 17 326
Hsu-Ping Kuo United States 8 150 0.7× 72 0.4× 186 1.3× 123 1.4× 174 2.3× 10 409
Kirsty Wienand United States 7 192 0.9× 87 0.5× 233 1.6× 238 2.6× 93 1.2× 15 399
Sara Tedoldi United Kingdom 8 177 0.9× 70 0.4× 169 1.2× 204 2.3× 70 0.9× 9 429
Ethan Strattan United States 6 186 0.9× 154 0.8× 117 0.8× 113 1.3× 49 0.7× 12 314

Countries citing papers authored by Valentina Griggio

Since Specialization
Citations

This map shows the geographic impact of Valentina Griggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Griggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Griggio more than expected).

Fields of papers citing papers by Valentina Griggio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Griggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Griggio. The network helps show where Valentina Griggio may publish in the future.

Co-authorship network of co-authors of Valentina Griggio

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Griggio. A scholar is included among the top collaborators of Valentina Griggio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Griggio. Valentina Griggio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Golovina, Elena A., Tomáš Heizer, Simona Fontana, et al.. (2024). MiR-155 deficiency and hypoxia results in metabolism switch in the leukemic B-cells. Cancer Cell International. 24(1). 251–251. 1 indexed citations
2.
Vitale, Candida, Valentina Griggio, Maria Chiara Todaro, et al.. (2023). Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia. Scientific Reports. 13(1). 16950–16950. 2 indexed citations
3.
Vitale, Candida, et al.. (2023). CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?. HemaSphere. 7(12). e988–e988. 7 indexed citations
4.
Vitale, Candida, Valentina Griggio, Daniela Drandi, et al.. (2022). Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights. Frontiers in Oncology. 12. 917115–917115. 3 indexed citations
5.
Jones, Rebecca, et al.. (2022). Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges. Frontiers in Oncology. 12. 837531–837531. 17 indexed citations
6.
Vitale, Candida, et al.. (2021). Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia. Cancers. 13(15). 3856–3856. 14 indexed citations
7.
Vitale, Candida, Valentina Griggio, Chiara Riganti, et al.. (2021). Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL. Cancers. 13(12). 2883–2883. 14 indexed citations
8.
Griggio, Valentina, et al.. (2020). Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia. Frontiers in Immunology. 11. 594556–594556. 51 indexed citations
9.
Vitale, Candida, et al.. (2020). Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. Cancers. 12(2). 282–282. 23 indexed citations
10.
Griggio, Valentina, Candida Vitale, Francesca Romana Mauro, et al.. (2020). CLL-220: Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Clinical Lymphoma Myeloma & Leukemia. 20. S224–S225.
11.
Griggio, Valentina, Candida Vitale, Francesca Romana Mauro, et al.. (2019). Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia. Blood. 134(Supplement_1). 3031–3031. 4 indexed citations
12.
Griggio, Valentina, Candida Vitale, Maria Chiara Todaro, et al.. (2018). Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia. Blood. 132(Supplement 1). 4412–4412. 2 indexed citations
13.
Vitale, Candida, et al.. (2017). Magic pills: new oral drugs to treat chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy. 18(4). 411–425. 8 indexed citations
14.
Griggio, Valentina, Giorgia Mandili, Candida Vitale, et al.. (2016). Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia. Oncotarget. 8(2). 3274–3288. 13 indexed citations
15.
Riganti, Chiara, Candida Vitale, Valentina Griggio, et al.. (2015). Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells. Oncotarget. 6(30). 29833–29846. 35 indexed citations
16.
Castella, Barbara, Myriam Foglietta, Marta Coscia, et al.. (2015). Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma. OncoImmunology. 4(11). e1047580–e1047580. 59 indexed citations
17.
Coscia, Marta, Candida Vitale, Silvia Peola, et al.. (2012). Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. Blood. 120(16). 3271–3279. 53 indexed citations
18.
Coscia, Marta, Francesca Pantaleoni, Chiara Riganti, et al.. (2011). IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells. Leukemia. 25(5). 828–837. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ewa Wąsik‐Szczepanek Breakdown of academic impact, for papers by Pamela Ranghetti Breakdown of academic impact, for papers by Jenny Bulgarelli Breakdown of academic impact, for papers by Noelia Purroy Breakdown of academic impact, for papers by Patricia Johansson Breakdown of academic impact, for papers by Zsolt Zoltán Fülöp Breakdown of academic impact, for papers by Hsu-Ping Kuo Breakdown of academic impact, for papers by Kirsty Wienand Breakdown of academic impact, for papers by Sara Tedoldi Breakdown of academic impact, for papers by Ethan Strattan
Rankless by CCL
2026